Growth Metrics

Protalix BioTherapeutics (PLX) Gross Margin (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3,841.00
Dec 31, 2025 -401.00
Sep 30, 2025 -914.00
Jun 30, 2025 4,340.00
Mar 31, 2025 -5,956.00
Dec 31, 2024 2,530.00
Sep 30, 2024 2,355.00
Jun 30, 2024 -76.00
Mar 31, 2024 1,503.00
Dec 31, 2023 -3,716.00
Sep 30, 2023 -2,977.00
Jun 30, 2023 1,465.00
Mar 31, 2023 -436.00
Dec 31, 2022 2,206.00
Sep 30, 2022 -318.00
Jun 30, 2022 -918.00
Mar 31, 2022 -69.00
Dec 31, 2021 -610.00
Sep 30, 2021 4,292.00
Jun 30, 2021 -3,155.00
Mar 31, 2021 -2,798.00
Dec 31, 2020 1,246.00
Sep 30, 2020 -992.00
Jun 30, 2020 -83.00
Mar 31, 2020 528.00
Dec 31, 2019 139.00
Sep 30, 2019 -49.00
Jun 30, 2019 -242.00
Mar 31, 2019 11,014.00
Dec 31, 2018 15,941.00
Sep 30, 2018 -18,032.00
Jun 30, 2018 -4,460.00
Mar 31, 2018 -1,505.00
Dec 31, 2017 3,143.00
Sep 30, 2017 627.00
Jun 30, 2017 -3,553.00
Mar 31, 2017 4,246.00
Dec 31, 2016 -284.00
Sep 30, 2016 372.00
Jun 30, 2016 -1,766.00
Sep 30, 2015 15.00
Jun 30, 2015 -17.00
Mar 31, 2014 -3,084.00
Dec 31, 2013 269.00
Sep 30, 2013 46.00
Jun 30, 2013 -688.00
Mar 31, 2013 18,041.00
Dec 31, 2012 -17,759.00
Sep 30, 2012 -299.00
Jun 30, 2012 2,180.00
Mar 31, 2012 4,992.00
Dec 31, 2011 -4,736.00
Sep 30, 2011 68,153.00
Jun 30, 2011 -74,823.00
Mar 31, 2011 -15,258.00
Dec 31, 2010 21,253.00
Sep 30, 2010 1,283.00